As there are varied regimens for recurrent ovarian cancer, even for one patient, the regimens would change based on the response to chemotherapy.
There are varied regimens in use for patients with locally advanced disease, but at the same time the multitude of options can plague the clinician when trying to select the most appropriate one.
Among HIV-infected children in the UK and Ireland, rates of viral load suppression by 12 months were similarly high for different first-line regimens, whereas time to virological failure varied by regimen.
Although progression to failure varied by regimen (P < 0.001) and was fastest for NVP + 2NRTIs regimens, risk after 2 years on therapy was similar for EFV + 2NRTIs and NVP + 2NRTIs, and lowest for NNRTI + 3NRTIs regimens (P-interaction = 0.03).
Unfortunately, Coley failed to establish a standard procedure but rather varied the regimen (extract preparation, treatment duration, injection frequency, injection site, dosage) throughout his career, making it difficult to compare his case studies and to pinpoint crucial parameters.
Median progression-free survival from initiation of second-line treatment varied across regimens from 2.0 to 6.6 months (overall median, 5.4 months).
WHIMS-Y will examine whether an average of 5.4 years of HT during early menopause has longer term protective effects on global cognitive function and if these effects vary by regimen, time between menopause and study initiation, and prior use of HT.
The association of insulin dose with hypoglycemia did not vary by regimen type, as indicated by a statistically nonsignificant interaction term in the multivariate model (P = 0.524).
Our findings suggest that long duration use of both unopposed estrogens and oestrogen plus progestins are associated with increased risks of ovarian cancer, and that risk associated with oestrogen plus progestin use does not vary by regimen (sequential or continuous).
In conclusion, our results suggest that long duration use of both unopposed estrogens and oestrogen plus progestins are associated with increased risks of ovarian cancer, and that risk associated with oestrogen plus progestin use does not vary by regimen (sequential or continuous).
